- | Pays :
- Austria
- France
- Germany
- Les 4 autres...
- | Organes : -
- | Spécialités : -
Extrait
This is a phase III European multicenter, open label, prospective study to assess the diagnostic accuracy of the use of SonoVue contrast agent to guide prostate biopsies in comparison with the current practice of ultrasound guided systematic biopsy. The trial will involve 15-20 European Centers.
Critère d'inclusion
- Prostate cancer